- Home
- CRBP vs PBHC Comparison
CRBP vs PBHC Comparison
Compare CRBP & PBHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBP
- PBHC
- Stock Information
- Founded
- CRBP 2009
- PBHC 1859
- Country
- CRBP United States
- PBHC United States
- Employees
- CRBP N/A
- PBHC N/A
- Industry
- CRBP Biotechnology: Pharmaceutical Preparations
- PBHC Major Banks
- Sector
- CRBP Health Care
- PBHC Finance
- Exchange
- CRBP Nasdaq
- PBHC Nasdaq
- Market Cap
- CRBP 96.5M
- PBHC 91.0M
- IPO Year
- CRBP N/A
- PBHC N/A
- Fundamental
- Price
- CRBP $8.22
- PBHC $15.07
- Analyst Decision
- CRBP Strong Buy
- PBHC
- Analyst Count
- CRBP 10
- PBHC 0
- Target Price
- CRBP $53.56
- PBHC N/A
- AVG Volume (30 Days)
- CRBP 214.0K
- PBHC 4.0K
- Earning Date
- CRBP 08-05-2025
- PBHC 07-28-2025
- Dividend Yield
- CRBP N/A
- PBHC 2.65%
- EPS Growth
- CRBP N/A
- PBHC N/A
- EPS
- CRBP N/A
- PBHC 0.53
- Revenue
- CRBP N/A
- PBHC $41,317,000.00
- Revenue This Year
- CRBP N/A
- PBHC N/A
- Revenue Next Year
- CRBP $150.03
- PBHC N/A
- P/E Ratio
- CRBP N/A
- PBHC $28.89
- Revenue Growth
- CRBP N/A
- PBHC 1.46
- 52 Week Low
- CRBP $4.64
- PBHC $12.79
- 52 Week High
- CRBP $61.90
- PBHC $19.86
- Technical
- Relative Strength Index (RSI)
- CRBP 54.23
- PBHC 53.22
- Support Level
- CRBP $7.26
- PBHC $14.80
- Resistance Level
- CRBP $7.90
- PBHC $15.29
- Average True Range (ATR)
- CRBP 0.53
- PBHC 0.17
- MACD
- CRBP -0.01
- PBHC 0.04
- Stochastic Oscillator
- CRBP 78.59
- PBHC 86.02
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
About PBHC Pathfinder Bancorp Inc. (MD)
Pathfinder Bancorp Inc is a holding company for Pathfinder Bank. The Pathfinder Bank is a commercial bank engaged in attracting deposits from the general public and investing such deposits, together with other sources of funds, in loans secured by residential real estate, commercial real estate, small business loans, and consumer loans. The bank invests a portion of its assets in debt securities issued by the United States Government and its agencies and sponsored enterprises, state and municipal obligations, corporate debt securities, mutual funds, and equity securities. The principal source of income is interest on loans and investment securities.